Radoff Bradley Louis 13D/13G Filings for Opiant Pharmaceuticals, Inc. (OPNT)

Radoff Bradley Louis 13D and 13G filings for Opiant Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
2:28 pm
Sale
2020-12-3113GOpiant Pharmaceuticals, Inc.
OPNT
Radoff Bradley Louis18,000
1.000%
-259,500decrease
(-93.51%)
Filing